These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 11889238

  • 21. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, Hänninen T, Ryynänen M, Riekkinen PJ.
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [Abstract] [Full Text] [Related]

  • 22. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW.
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [Abstract] [Full Text] [Related]

  • 23. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
    Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J.
    Proc Natl Acad Sci U S A; 2004 Jan 06; 101(1):284-9. PubMed ID: 14688411
    [Abstract] [Full Text] [Related]

  • 24. Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence.
    Jelic V, Julin P, Shigeta M, Nordberg A, Lannfelt L, Winblad B, Wahlund LO.
    J Neurol Neurosurg Psychiatry; 1997 Jul 06; 63(1):59-65. PubMed ID: 9221969
    [Abstract] [Full Text] [Related]

  • 25. Apolipoprotein E epsilon4 allele frequency in vascular dementia.
    Davidson Y, Gibbons L, Purandare N, Byrne J, Hardicre J, Wren J, Payton A, Pendleton N, Horan M, Burns A, Mann DM.
    Dement Geriatr Cogn Disord; 2006 Jul 06; 22(1):15-9. PubMed ID: 16645276
    [Abstract] [Full Text] [Related]

  • 26. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C, Bizzarro A, Daniele A, De Luca L, Ferraccioli M, Valenza A, Brahe C, Tiziano FD, Gainotti G, Masullo C.
    Dement Geriatr Cogn Disord; 2004 Jul 06; 18(2):125-31. PubMed ID: 15211066
    [Abstract] [Full Text] [Related]

  • 27. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, Jakobsson J, Herukka SK, Owenius R, Olsson B, Hampel H, Rujescu D, Ewers M, Landén M, Minthon L, Blennow K, Zetterberg H, Hansson O, Alzheimer’s Disease Neuroimaging Initiative.
    JAMA Psychiatry; 2014 Oct 06; 71(10):1183-91. PubMed ID: 25162367
    [Abstract] [Full Text] [Related]

  • 28. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R, Mariani E, Camarda C, Ingegni T, Averna MR, Senin U, Camarda R, Mecocci P.
    Acta Psychiatr Scand; 2006 Jan 06; 113(1):59-63. PubMed ID: 16390371
    [Abstract] [Full Text] [Related]

  • 29. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.
    Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, Wang LS, Romero K, Arneric SP, Redolfi A, Orlandi D, Frisoni GB, Au R, Devine S, Auerbach S, Espinosa A, Boada M, Ruiz A, Johnson SC, Koscik R, Wang JJ, Hsu WC, Chen YL, Toga AW.
    JAMA Neurol; 2017 Oct 01; 74(10):1178-1189. PubMed ID: 28846757
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
    Quiroga P, Calvo C, Albala C, Urquidi J, Santos JL, Pérez H, Klaassen G.
    Neuroepidemiology; 1999 Oct 01; 18(1):48-52. PubMed ID: 9831815
    [Abstract] [Full Text] [Related]

  • 32. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
    Olarte L, Schupf N, Lee JH, Tang MX, Santana V, Williamson J, Maramreddy P, Tycko B, Mayeux R.
    Arch Neurol; 2006 Nov 01; 63(11):1586-90. PubMed ID: 17101827
    [Abstract] [Full Text] [Related]

  • 33. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.
    Minthon L, Hesse C, Sjögren M, Englund E, Gustafson L, Blennow K.
    Neurosci Lett; 1997 Apr 18; 226(1):65-7. PubMed ID: 9153643
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease.
    Corey-Bloom J, Tiraboschi P, Hansen LA, Alford M, Schoos B, Sabbagh MN, Masliah E, Thal LJ.
    Neurology; 2000 Jan 25; 54(2):403-6. PubMed ID: 10668702
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.
    Høgh P, Knudsen GM, Kjaer KH, Jørgensen OS, Paulson OB, Waldemar G.
    J Geriatr Psychiatry Neurol; 2001 Jan 25; 14(1):42-51. PubMed ID: 11281316
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.